<![CDATA[Hansa Biopharma announces positive topline data &lpar;AMR&rpar;]]>Hansa Biopharma announces positive topline data from the imlifidase phase 2 study in antibody mediated rejection (AMR) episodes post kidney transplantation

28 Nov 2022, 18:00 Regulatory information

"Hansa Biopharma announces positive topline data from the imlifidase phase 2 study in antibody mediated rejection (AMR) episodes post kidney transplantation"

Link Preview Image
Hansa Biopharma announces positive topline data from the imlifidase phase 2 study in antibody mediated rejection (AMR) episodes post kidney transplantation | Hansa Biopharma

favicon

(www.hansabiopharma.com)

]]>https://dev.proinvestor.com/forum/topic/444531/hansa-biopharma-announces-positive-topline-data-lparamrrparRSS for NodeSun, 28 Jun 2026 06:40:46 GMTMon, 28 Nov 2022 17:14:33 GMT60<![CDATA[Reply to Hansa Biopharma announces positive topline data &lpar;AMR&rpar; on Tue, 29 Nov 2022 05:00:10 GMT]]>"hvad var"

]]>https://dev.proinvestor.com/forum/post/9478981https://dev.proinvestor.com/forum/post/9478981Tue, 29 Nov 2022 05:00:10 GMT<![CDATA[Reply to Hansa Biopharma announces positive topline data &lpar;AMR&rpar; on Mon, 28 Nov 2022 19:53:23 GMT]]>Fantastisk, men var resultatet egentlig af forsøget? 🙂

]]>https://dev.proinvestor.com/forum/post/9478982https://dev.proinvestor.com/forum/post/9478982Mon, 28 Nov 2022 19:53:23 GMT